TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.

Oncotarget · 2014 · PMC4057604 · PMID 24742492

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

We observed that tumors expressing TBX2 showed an increased tendency towards metastasis while CST6 expressing tumors showed a trend towards a decrease in metastatic potential.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.